Crain's Chicago Business

It’s not clear how much of a case the defense teams plan to mount when the Chicago trial resumes next week.

The hot Chicago startup badly missed revenue targets as it was completing a major venture-capital deal — just one of several new details revealed in court.

The fund manager knew there would be trouble after he read a Wall Street Journal story that accused the startup of overbilling and misleading drug companies.

Collin Williams worried that a whistleblower's allegations of widespread fraud would put the company at risk.

Prosecutors and defense attorneys painted very different pictures for the jury as the fraud case approaches the halfway point.

The decision comes just days after California Gov. Gavin Newsom said the state would stop doing business with the pharmacy retail giant.

Rishi Shah's defense attorney took his shots at star witness Ashik Desai, who testified as part of a plea deal with prosecutors.

Held up as a success, the company was drowning in debt after the Accent Health acquisition and worried about missing sales targets, according to trial evidence.

Ashik Desai, who cut a plea deal, details how the company is alleged to have secretly overbilled advertisers such as AbbVie.

Robert Spadoni is accused of stealing more than $600,000 from Rush Oak Park Hospital.

Former Outcome Health analyst David Ma described the inner workings of the high-flying healthcare advertising company that led to fraud charges.

CEO and co-founder Mike Pykosz could receive more than $300 million cash in the acquisition.

An early employee tells a jury there were questions inside and outside the company.

The nonproft says it is using its purchase of CTCA to build a national cancer powerhouse.

One prosecutor told jurors the case against co-founders Rishi Shah and Shradha Agarwal and former COO Brad Purdy is about “ambition, greed and fraud.”